Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease.
The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Company profile from EODHD, stored Nov 4, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Nov 2, 2026 | $83.3M | +81.6% | 83.2% | -$41.9M | -$49.4M |
| Jun 2026filed Aug 4, 2026 | $72.8M | +91.8% | 95.6% | -$40.0M | -$49.4M |
| Mar 2026filed Apr 30, 2026 | $64.9M | +223.6% | 95.9% | -$34.2M | -$42.7M |
| Dec 2025filed Feb 26, 2026 | $68.5M | +791.7% | — | -$62.5M | -$68.0M |
| Sep 2025filed Nov 3, 2025 | $45.9M | +267.0% | 95.4% | -$57.4M | -$60.7M |
| Jun 2025filed Aug 4, 2025 | $38.0M | +984.5% | 96.6% | -$69.4M | -$71.8M |
| Mar 2025filed May 5, 2025 | $20.0M | — | 95.6% | -$83.8M | -$84.8M |
| Dec 2024filed Mar 3, 2025 | $7.7M | +1,332.8% | — | -$96.4M | -$94.2M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 26, 2026 | $172.4M | +627.8% | 96.0% | -$273.1M | -$285.4M |
| Dec 2024filed Mar 3, 2025 | $23.7M | — | 96.5% | -$339.7M | -$318.8M |
| Dec 2023filed Feb 27, 2024 | — | — | — | -$230.0M | -$209.4M |
| Dec 2022filed Feb 28, 2023 | $126.6M | -9.4% | — | -$151.8M | -$143.7M |
| Dec 2021filed Mar 1, 2022 | $139.7M | +9,109.6% | 100.0% | $26.2M | $24.9M |
| Dec 2020filed Mar 12, 2021 | $1.5M | 0.0% | 100.0% | -$71.4M | -$73.1M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched SNDX. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
18,001,644 shares short
-233,236 shares (-1.3%) vs Sep 30, 2026
22.4% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
18,234,880 shares short
-2,425,569 shares (-11.7%) vs Sep 15, 2026
22.7% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
20,660,449 shares short
-1,021,458 shares (-4.7%) vs Aug 31, 2026
26.1% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
21,681,907 shares short
-1,220,524 shares (-5.3%) vs Aug 14, 2026
27.4% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
22,902,431 shares short
+237,215 shares (+1%) vs Jul 31, 2026
29% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
22,665,216 shares short
+1,849,106 shares (+8.9%) vs Jul 15, 2026
28.7% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind SNDX’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if SNDX is in your portfolio and how much it contributes.
Sign inLoading market dates
41 smart-money holders: institutions with a high Holder IQ
Smart-money 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 8 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 1
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
243 filers reported a long position in SNDX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
44.7%
of the 108.1M shares 13-F filers reported
Moves vs Q1 2026
6 added2 trimmed
2 unchanged
Net shares held
+7.4%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $197.2M · 9M shares | 9M | +9.3% |
| 2 | Kynam Capital Management, LP | $176M · 8.1M shares | 8.1M | Unchanged |
| 3 | GOLDMAN SACHS GROUP INC | $128.1M · 5.9M shares | 5.9M | +17.3% |
| 4 | STATE STREET CORP | $123.7M · 5.7M shares | 5.7M | +27.7% |
| 5 | BANK OF AMERICA CORP /DE/ | $88.4M · 4M shares | 4M | -4.8% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $85.9M · 3.9M shares | 3.9M | +2.8% |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. | $82.6M · 3.8M shares | 3.8M | Unchanged |
| 8 | Eversept Partners, LP | $61.2M · 2.8M shares | 2.8M | -3% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $56.5M · 2.6M shares | 2.6M | +19.8% |
| 10 | Hood River Capital Management LLC | $56.1M · 2.6M shares | 2.6M | +8.9% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of SNDX file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 7, 2026 | STATE STREET CORP13G · passive | 6.4% |
| May 15, 2026 | Point72 Asset Management, L.P.13G · passive · amended | 2.3%under 5% |
| Apr 30, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive | 5.05% |
| Mar 27, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.